Literature DB >> 3773540

Predictors of reoperation after myocardial revascularization.

D M Cosgrove, F D Loop, B W Lytle, C C Gill, L A Golding, C Gibson, R W Stewart, P C Taylor, M Goormastic.   

Abstract

The first 1,000 patients undergoing primary isolated myocardial revascularization each year from 1971 to 1978 were analyzed to define the incidence of reoperation and to elucidate the determinants of reoperation and reoperation-free survival. Six hundred sixty-six patients (9.7%) underwent reoperation in a mean of 6.9 +/- 3.2 years. Cumulative percent reoperation was 2.7% at 5 years, 11.4% at 10 years, and 17.3% at 12 years. The annual incidence of reoperation was 1.1% at 5 years and increased to 3.9% at 12 years. Twenty-five patient descriptors were analyzed for predictors of reoperation. Young age was found to be the most important predictor of potential for reoperation. Other risk factors in descending order of significance were absence of an internal mammary artery graft, incomplete revascularization, New York Heart Association Functional Class III/IV, and single or double vessel disease. Absence of an internal mammary artery graft was an important predictor for all age groups. In the multivariate analyses for risk factors for reoperation-free survival, absence of an internal mammary artery graft was the most important predictor. Other factors of major significance were smoking, incomplete revascularization, and moderate/severe left ventricular impairment. Internal mammary artery grafting neutralizes hypertension, serum cholesterol level higher than 300 mg/dl, and smoking as risk factors for reoperation-free survival.

Entities:  

Mesh:

Year:  1986        PMID: 3773540

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

Review 1.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Is diabetes mellitus a major risk factor in coronary artery bypass grafting? The influence of internal thoracic artery grafting on late survival in diabetic patients.

Authors:  T Yamamoto; Y Hosoda; K Takazawa; I Hayashi; H Miyagawa; S Sasaguri
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-06

3.  Redo coronary artery bypass grafting: early and mid-term results.

Authors:  Hitoshi Hirose; Atsushi Amano; Akihito Takahashi; Shuichirou Takanashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-01

4.  The internal mammary artery bypass graft: praise versus practice.

Authors:  E A Lefrak
Journal:  Tex Heart Inst J       Date:  1987-06

5.  Metabolic profiles predict adverse events after coronary artery bypass grafting.

Authors:  Asad A Shah; Damian M Craig; Jacqueline K Sebek; Carol Haynes; Robert C Stevens; Michael J Muehlbauer; Christopher B Granger; Elizabeth R Hauser; L Kristin Newby; Christopher B Newgard; William E Kraus; G Chad Hughes; Svati H Shah
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02-04       Impact factor: 5.209

6.  Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients.

Authors:  F D Loop; B W Lytle; D M Cosgrove; E L Woods; R W Stewart; L A Golding; M Goormastic; P C Taylor
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

Review 7.  Reoperation after coronary bypass grafting.

Authors:  A H Menkis; S D Carley; T M Clough
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

8.  A cautionary tale of undetected hyperlipidaemia: implications for coronary artery bypass grafting.

Authors:  R Naoumova; B Keogh; K Taylor; G R Thompson
Journal:  Br Heart J       Date:  1994-11

Review 9.  Redo coronary artery bypass grafting.

Authors:  Hitoshi Yaku; Kiyoshi Doi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-07

10.  [Ambulatory cardiac phase II rehabilitation--"the Cologne model"--including 3-year-outcome after termination of rehabilitation].

Authors:  B Bjarnason-Wehrens; H G Predel; C Graf; R Rost
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.